mental health

R&D

pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.

Patients

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Patients

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

News

Entropy signs Pre-CTA with UCSF to develop a US-based Phase 2 trial comparing IV psilocin treatment directly against escitalopram (Lexapro) in MDD.

Patients

After a schizophrenia diagnosis, families must learn how to navigate treatment, respond to symptoms, and communicate effectively.

Digital

The state of the public’s mental health in the UK and Europe is a serious unmet need.